Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.

Wessels MH, Van Lierop ZY, Noteboom S, Strijbis EM, Heijst JA, Van Kempen ZL, Moraal B, Barkhof F, Uitdehaag BM, Schoonheim MM, Killestein J, Teunissen CE

Open source

DOI: 10.1177/13524585231188625
Published: 2023 Sep
Container: Multiple sclerosis (Houndmills, Basingstoke, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/13524585231188625,
  title = {Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.},
  author = {Wessels MH and Van Lierop ZY and Noteboom S and Strijbis EM and Heijst JA and Van Kempen ZL and Moraal B and Barkhof F and Uitdehaag BM and Schoonheim MM and Killestein J and Teunissen CE},
  year = {2023},
  journal = {Multiple sclerosis (Houndmills, Basingstoke, England)},
  doi = {10.1177/13524585231188625},
  url = {https://doi.org/10.1177/13524585231188625}
}

RIS

TY  - JOUR
TI  - Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.
AU  - Wessels MH
AU  - Van Lierop ZY
AU  - Noteboom S
AU  - Strijbis EM
AU  - Heijst JA
AU  - Van Kempen ZL
AU  - Moraal B
AU  - Barkhof F
AU  - Uitdehaag BM
AU  - Schoonheim MM
AU  - Killestein J
AU  - Teunissen CE
PY  - 2023
JO  - Multiple sclerosis (Houndmills, Basingstoke, England)
DO  - 10.1177/13524585231188625
UR  - https://doi.org/10.1177/13524585231188625
ER  -

APA

MH, W., ZY, V. L., S, N., EM, S., JA, H., ZL, V. K., B, M., F, B., BM, U., MM, S., J, K., & CE, T. (2023). Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.. Multiple sclerosis (Houndmills, Basingstoke, England). https://doi.org/10.1177/13524585231188625

Source records

pubmed · retrieved 2026-09-26T13:53:31.036Z